The Safety of STSA-1002 Following Intravenous Infusion in Healthy Subjects

NCT05166837 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: STSA-1002 injection
DRUG: Placebo
DRUG: STSA-1002 injection
DRUG: Placebo
DRUG: STSA-1002 injection
DRUG: Placebo
DRUG: STSA-1002 injection
DRUG: Placebo
DRUG: STSA-1002 injection
DRUG: Placebo

Sponsor

Staidson (Beijing) Biopharmaceuticals Co., Ltd